Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

D Gregory Perry


  • Director at Merus N.v. (MRUS), 2020-07-02
  • Director at Kala Pharmaceuticals Inc. (KALA), 2019-06-07
  • See Remarks at Novelion Therapeutics Inc. (NVLN), 2017-05-11
  • Other at Aegerion Pharmaceuticals Inc. (AEGR), 2016-12-01
  • Director at Ocata Therapeutics Inc. (OCAT), 2016-01-04
  • Chief Financial And Business at Eleven Biotherapeutics Inc. (EBIO), 2014-02-06
  • Interim Cfo at Invivo Therapeutics Holdings Corp. (NVIV), 2014-01-02
  • Chief Financial Officer at Immunogen Inc (IMGN), 2013-09-11
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
IMGN $17.82 18,337 Officer 0 2013-09-10 Filing
IMGN $12.58 8,333 Officer 0 2011-11-15 Filing
IMGN $13.40 8,333 Officer 0 2011-10-17 Filing
IMGN $11.00 8,333 Officer 0 2011-09-26 Filing
IMGN $11.06 8,333 Officer 0 2011-08-15 Filing